Pharmabiz

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...
Le Lézard

FDA Approves Omeros' YARTEMLEA® ? First and Only Therapy Indicated for TA-TMA

Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...